VVOS - Vivos Therapeutics Inc

https://www.vivos.com

Recent News

Motley Fool • 3 weeks, 5 days ago • score: 0.37

Vivos Therapeutics ( NASDAQ:VVOS ) reported second quarter 2025 results on August 20, 2025, marking a pivotal shift from its legacy dentist-focused model to a direct, patient-centric sleep center strategy. Revenue declined 6% year over year to $3.8 million, but the recent acquisition of the Sleep ...

Interval:

EMA1: EMA2:

AI Tools

Key Metrics

Trend: Downtrend

Source: Snapshot

Vivos Therapeutics, Inc., a medical technology company, is dedicated to developing and commercializing treatment alternatives for patients with sleep-disordered breathing, such as mild to moderate obstructive sleep apnea (OSA). The company is headquartered in Highlands Ranch, Colorado.

52W High

$7.95

52W Low

$1.98

MA Status:

50D: Below 200D: Below

Beta (~1 neutral, <0.9 lower risk)

6.99

Valuation

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

N/A

Forward P/E (<15 better)

N/A

EV/EBITDA (<8 favorable)

-0.21

EV/Revenue (<3 favorable)

2.65

P/S (TTM) (<3 favorable)

2.15

P/B (<3 favorable)

6.75

Ownership

Retail‑heavy

Source: Overview

Insiders (1–5% typical)

29.53%

Institutions (25–75% balanced)

10.57%

Shares Outstanding

7,504,800

Float

5,434,200

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

14,393,000

Gross Profit (TTM)

8,047,000

EPS (TTM)

-1.16

Profit Margin (>10% good)

-1.00%

Operating Margin (TTM) (higher better)

-1.27%

ROE (TTM) (>15% strong)

-2.62%

EPS YoY (Quarterly) (>10% good)

N/A

Revenue YoY (Quarterly) (>8% good)

-0.06

Momentum

Value

N/A

Trend

—

Signal Cross

No cross

As of

—